Nabumetone NDC 87063-292

Product information

Brand name (proprietary)

Nabumetone

Generic name (nonproprietary)

nabumetone

Active ingredients

Nabumetone — 750 mg/1

Dosage form

Tablet

Route

Oral

Labeler

ASCLEMED USA INC.

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 078420

Marketing start

Jun 26, 2019

Listing expires

Dec 31, 2027

Other FDA classes

Non-Steroidal (Chemical structure)Cyclooxygenase Inhibitors (Mechanism)

Identifiers

Product ID 87063-292_595fd0eb-93f8-a085-e063-6294a90a46eaSPL ID 595fd0eb-93f8-a085-e063-6294a90a46ea

Pharmacologic class

Nonsteroidal Anti-inflammatory Drug

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N487063029201 followed by a unit qualifier and the quantity Copy

Package 87063-0292-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

Other NDCs under ANDA 078420

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

Showing 20 of 39.